Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy—defibrillators

Adelstein, Evan; D. Althouse, Andrew; Davis, Lydia; Schwartzman, David; Bazaz, Raveen; Jain, Sandeep; C. Wang, Norman; Saba, Samir

doi:10.1111/jce.13828

Public

Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy—defibrillators

Published in Journal of Cardiovascular Electrophysiology • Dec 21, 2018

Authors:

Evan Adelstein

Andrew D. Althouse

Lydia Davis

Abstract

INTRODUCTION: Amiodarone reduces recurrent ventricular tachyarrhythmias (VTA) but may worsen cardiovascular outcomes in heart failure (HF) patients. Cardiac resynchronization therapy (CRT) may also be antiarrhythmic. When patients with prior sustained VTA are upgraded to CRT defibrillators (CRT-D) f...

Subject

Medicine

Amiodarone

Cardiology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!